RINO1 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
RINO1 antibody; INO1 antibody; INO1-1 antibody; Os03g0192700 antibody; LOC_Os03g09250 antibody; Inositol-3-phosphate synthase 1 antibody; MIP synthase 1 antibody; EC 5.5.1.4 antibody; Myo-inositol 1-phosphate synthase antibody; IPS antibody; MI-1-P synthase antibody; OsINO1-1 antibody
Target Names
RINO1
Uniprot No.

Target Background

Function
RINO1 Antibody targets an enzyme involved in myo-inositol synthesis. It plays a crucial role in the phytic acid biosynthesis pathway within seeds.
Database Links
Protein Families
Myo-inositol 1-phosphate synthase family
Subcellular Location
Cytoplasm.
Tissue Specificity
Highly expressed in embryos, but transcripts are undetectable in roots, leaves, flowers and anthers.

Q&A

What is RINO1 and what is its biological significance in plant research?

RINO1 (Rice ins(3)P synthase1, EC 5.5.1.4) is a key enzyme in the inositol biosynthetic pathway in rice (Oryza sativa). It catalyzes the conversion of glucose-6-phosphate to inositol-3-phosphate, which is a crucial step in phytic acid (InsP6) biosynthesis.

RINO1 has significant biological importance as it:

  • Plays a critical role in embryonic development in rice

  • Regulates auxin synthesis and distribution through inositol-associated pathways

  • Influences seed germination performance

  • Affects phosphatidylinositides (PIs) concentration, which impacts vesicle trafficking

Research has shown that homozygous RINO1 knockout plants exhibit significant developmental abnormalities, particularly in embryo formation, where they fail to develop normal differentiation of plumule and radicle primordia .

What are the available methods for RINO1 antibody validation in plant tissue samples?

Several approaches can be used to validate RINO1 antibodies for plant research:

  • Western Blot Analysis:

    • Using RINO1 knockout/knockdown lines as negative controls

    • Testing across multiple tissue types to confirm expected molecular weight

    • Testing recombinant RINO1 protein as a positive control

  • Immunohistochemistry Cross-Validation:

    • Compare staining patterns with mRNA expression data from in situ hybridization

    • Use blocking peptides to confirm specificity

    • Include appropriate isotype controls

  • Advanced Validation Techniques:

    • Mass spectrometry validation of immunoprecipitation products

    • Competitive binding assays with the immunizing peptide

As shown in research on antibody validation, approximately 50-75% of antibodies demonstrate high performance in their intended applications, but validation across multiple applications is essential .

What sample preparation protocols are recommended for RINO1 detection in rice tissues?

For optimal RINO1 detection in rice tissues, consider the following protocol:

Seed/Embryo Preparation Protocol:

  • Fix tissue samples in 4% paraformaldehyde for 16-24 hours at 4°C

  • Dehydrate through an ethanol series (30%, 50%, 70%, 85%, 95%, 100%)

  • Clear with xylene and embed in paraffin

  • Section at 5-10 μm thickness

  • Deparaffinize and rehydrate sections

  • Perform antigen retrieval (citrate buffer, pH 6.0, 95°C for 20 minutes)

  • Block with 2% bovine serum albumin solution

  • Incubate with primary anti-RINO1 antibody (typically 1:100-1:500 dilution)

  • Wash and apply appropriate secondary antibody

  • Perform counterstaining as needed

For Western blot applications, extraction buffers containing phosphatase inhibitors are crucial as RINO1 functions within phosphorylation pathways .

What controls should be included in experiments using RINO1 antibodies?

When using RINO1 antibodies, include the following controls:

Essential Controls for RINO1 Antibody Experiments:

  • Positive Controls:

    • Wild-type rice tissue samples known to express RINO1

    • Recombinant RINO1 protein (if available)

  • Negative Controls:

    • RINO1 knockout or knockdown tissue samples

    • Primary antibody omission

    • Isotype-matched non-specific antibody

  • Specificity Controls:

    • Preabsorption with immunizing peptide

    • Secondary antibody only control

Research has demonstrated that knockout cell lines provide superior control compared to other types of controls for both Western blot and immunofluorescence applications .

How can RINO1 antibodies be used to investigate inositol metabolism in rice seed development?

RINO1 antibodies can be powerful tools for investigating inositol metabolism during rice seed development through several advanced approaches:

Methodological Applications:

  • Spatiotemporal Expression Analysis:

    • Immunohistochemistry on developing seeds at various stages (1-21 days post-fertilization)

    • Co-localization with other inositol pathway components

    • Quantitative Western blot analysis across developmental timepoints

  • Functional Analysis in Combination with Biochemical Assays:

    • Correlate protein levels with enzyme activity using radioactive or colorimetric assays

    • Combine antibody detection with metabolite measurements (inositol, PIs, InsP6)

    • Quantify downstream effects on auxin distribution using DR5 reporter lines

  • Protein-Protein Interaction Studies:

    • Co-immunoprecipitation to identify RINO1 interaction partners

    • Proximity ligation assays to confirm interactions in situ

Research has shown that RINO1 function impacts phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2) concentration, which affects auxin distribution and embryo development, making these parameters important to monitor in any comprehensive study .

What methodological approaches are recommended for studying RINO1 protein in the context of embryonic development?

For studying RINO1's role in embryonic development, consider these methodological approaches:

Recommended Research Design:

  • Temporal Expression Analysis:

    • Collect embryos at defined developmental stages (globular, heart, torpedo, mature)

    • Process parallel samples for protein extraction (Western blot) and fixation (immunolocalization)

    • Quantify RINO1 levels relative to housekeeping proteins across stages

  • Functional Manipulation Studies:

    • Compare wild-type, heterozygous, and homozygous RINO1 knockout embryos

    • Use inducible RNAi or CRISPR systems for stage-specific knockdown

    • Apply exogenous inositol and/or IAA treatments to test rescue capabilities

  • High-Resolution Localization:

    • Immunogold electron microscopy to determine subcellular localization

    • Super-resolution microscopy to visualize association with membrane structures

    • Co-localization with markers for shoot apex meristem (SAM) and radicle apex meristem (RAM)

Research has demonstrated that abnormal embryo phenotypes in RINO1 homozygous knockouts can be partially rescued by exogenous application of inositol and indole-3-acetic acid (IAA), suggesting direct connections between RINO1, inositol metabolism, and auxin signaling .

How can cross-reactivity issues with RINO1 antibodies be addressed in experimental design?

Cross-reactivity is a significant concern when working with plant protein antibodies. Here are strategies to address this issue:

Cross-Reactivity Mitigation Strategies:

  • Epitope Analysis and Selection:

    • Target unique regions of RINO1 with minimal homology to related proteins

    • Avoid conserved domains shared with other inositol synthases

    • Use epitope mapping to identify optimal antibody binding sites

  • Validation Approaches:

    • Test antibody against recombinant proteins from related family members

    • Perform immunoblotting in tissues with differential expression of RINO1 vs. related proteins

    • Use gene knockout lines as definitive negative controls

  • Absorption Controls:

    • Pre-absorb antibody with recombinant proteins of related family members

    • Compare staining patterns before and after absorption

Recent research on antibody characterization has shown that approximately 50% of commercial antibodies fail to meet basic standards for characterization, highlighting the importance of thorough validation .

What are the best approaches for quantifying RINO1 protein expression across different tissues and developmental stages?

For accurate quantification of RINO1 protein expression:

Quantification Methods and Considerations:

  • Western Blot Quantification:

    • Use fluorescent secondary antibodies for wider linear range

    • Include calibration curves with recombinant RINO1 protein standards

    • Normalize to multiple housekeeping proteins appropriate for each tissue type

    • Implement technical and biological replicates (minimum n=3)

  • Image-Based Quantification:

    • Apply consistent image acquisition parameters across all samples

    • Use automated image analysis algorithms to reduce bias

    • Include fluorescence standards to normalize between experiments

    • Quantify signal intensity relative to cell number or tissue area

  • Advanced Quantitative Approaches:

    • ELISA-based quantification for high-throughput analysis

    • Mass spectrometry with isotope-labeled standards for absolute quantification

    • Single-cell analysis using flow cytometry for cell-type specific expression

Tissue TypeRecommended Extraction BufferSuggested Loading ControlSpecial Considerations
Developing seedsRIPA with phosphatase inhibitorsHSP70, ActinHigh lipid content may interfere
EmbryosNP-40 with protease inhibitorsGAPDH, TubulinLimited material requires optimization
Vegetative tissuesTris-SDS with PVPPRuBisCO small subunitHigh phenolic compounds require PVPP
Root tissueHEPES with EDTA and DTTActin, EF1αSoil contaminants may affect quality

How can RINO1 antibodies be adapted for immunoprecipitation experiments to study protein interactions?

To optimize RINO1 antibodies for immunoprecipitation (IP) studies:

Immunoprecipitation Optimization Strategies:

  • Antibody Preparation:

    • Test both native and cross-linked antibody approaches

    • Optimize antibody-to-bead ratios (typically 5-10 μg antibody per 50 μl beads)

    • Consider using oriented coupling methods to maximize antigen-binding capacity

  • Extraction Conditions:

    • Test multiple extraction buffers (RIPA, NP-40, digitonin) to balance solubilization and preserved interactions

    • Include phosphatase inhibitors to maintain physiological interactions

    • Optimize salt concentration to reduce non-specific binding while maintaining specific interactions

  • Validation and Analysis:

    • Confirm pull-down of RINO1 by Western blot before proceeding to interaction analysis

    • Use mass spectrometry to identify interaction partners

    • Validate key interactions using reverse IP or proximity ligation assays

Recent antibody characterization studies have demonstrated that recombinant antibodies typically outperform both monoclonal and polyclonal antibodies in immunoprecipitation applications, suggesting they may be preferable for interaction studies .

What strategies can address the challenges of using antibodies to study RINO1 in low phytic acid (LPA) rice variants?

When studying RINO1 in LPA rice variants, researchers face unique challenges that require specialized approaches:

Methodological Strategies for LPA Research:

  • Sensitivity Enhancement Techniques:

    • Employ signal amplification methods (tyramide signal amplification for IHC)

    • Use high-sensitivity detection systems (chemiluminescent substrates with enhanced formulations)

    • Consider sample enrichment through subcellular fractionation

  • Comparative Analysis Approaches:

    • Develop standardized protocols for comparing wild-type vs. LPA variants

    • Use ratiometric measurements comparing RINO1 to other pathway components

    • Implement absolute quantification methods using recombinant protein standards

  • Functional Correlation Studies:

    • Correlate antibody detection with enzymatic activity measurements

    • Monitor downstream metabolites (InsP6, PI(4,5)P2) in parallel with protein levels

    • Track auxin distribution and signaling outputs as functional readouts

Research has shown that LPA rice with reduced RINO1 function exhibits compromised embryonic development, suggesting important connections between phytic acid metabolism and developmental signaling pathways that can be explored using well-validated antibodies .

What are the recommended storage and handling procedures to maintain RINO1 antibody stability?

Proper storage and handling are crucial for maintaining antibody performance:

Optimal Storage and Handling Guidelines:

  • Storage Recommendations:

    • Store concentrated antibody stocks at -20°C to -80°C in small aliquots to avoid freeze-thaw cycles

    • For working solutions, store at 4°C with appropriate preservatives (0.02-0.05% sodium azide)

    • Monitor expiration dates and performance over time with standard samples

  • Handling Best Practices:

    • Avoid repeated freeze-thaw cycles (limit to <5 cycles)

    • Allow antibodies to warm to room temperature before opening to prevent condensation

    • Use sterile technique when handling to prevent microbial contamination

    • Centrifuge briefly before opening to collect solution at the bottom of the tube

  • Stability Monitoring:

    • Periodically test antibody performance against standard samples

    • Document lot-to-lot variations using consistent positive controls

    • Consider adding stabilizing proteins (BSA, gelatin) for dilute working solutions

Most antibodies are stable for approximately 1 year at -20°C when properly aliquoted and stored, though performance should be regularly validated .

How do different fixation and antigen retrieval methods affect RINO1 detection in plant tissues?

Fixation and antigen retrieval significantly impact RINO1 antibody performance:

Effect of Different Preparation Methods:

Fixation MethodAdvantagesDisadvantagesRecommended Antigen Retrieval
4% ParaformaldehydePreserves tissue morphologyMay mask some epitopesCitrate buffer (pH 6.0), 95°C, 20 min
Ethanol-Acetic AcidGood for nucleic acid preservationMay extract some membrane proteinsNot typically required
MethanolGood for cytoskeletal proteinsPoor for membrane proteins0.1% Triton X-100, 15 min
GlutaraldehydeExcellent ultrastructure preservationStrong autofluorescenceSodium borohydride (0.1%, 15 min)
Fresh-frozenMinimal epitope maskingPoor morphologyNot required

For RINO1 detection in embryonic tissues, research suggests that 4% paraformaldehyde fixation followed by citrate buffer antigen retrieval provides optimal results for balancing epitope preservation with tissue morphology .

How can specificity of RINO1 antibodies be thoroughly validated across different experimental applications?

Comprehensive validation is essential for ensuring RINO1 antibody specificity:

Multi-parameter Validation Strategy:

  • Application-Specific Validation:

    • For each application (WB, IHC, IP), perform separate validation protocols

    • Document optimal working dilutions for each application

    • Test performance across multiple tissue types and developmental stages

  • Technical Validation Approaches:

    • Western blot analysis showing a single band of appropriate molecular weight

    • Peptide competition assays showing signal reduction with increasing peptide concentration

    • Immunoprecipitation followed by mass spectrometry identification

    • Testing in knockout/knockdown tissues or RNAi-treated samples

  • Cross-reactivity Assessment:

    • Test against recombinant proteins of related family members

    • Perform sequence alignment analysis to identify potential cross-reactive epitopes

    • Document any non-specific binding observations

Research on antibody validation has demonstrated that up to 75% of protein targets can be covered by at least one high-performing commercial antibody, but thorough validation across multiple applications is essential .

What are the considerations for selecting secondary antibodies for RINO1 detection systems?

Selecting appropriate secondary antibodies is crucial for optimal RINO1 detection:

Secondary Antibody Selection Criteria:

  • Host Species Considerations:

    • Choose secondary antibodies raised against the species of the primary antibody

    • Consider potential cross-reactivity with endogenous plant immunoglobulins

    • For multiple labeling, select secondary antibodies raised in different hosts

  • Conjugate Selection:

    • For Western blot: HRP or AP for chemiluminescent/colorimetric detection; fluorescent for multiplexing

    • For IHC/IF: Fluorophores with spectral properties matching available microscopy filters

    • For specialized applications: Nanogold particles for EM studies or biotin for signal amplification

  • Validation Parameters:

    • Test secondary-only controls to assess non-specific binding

    • Determine optimal dilution to maximize signal-to-noise ratio

    • Evaluate batch-to-batch consistency with standardized samples

Research has shown that secondary antibody selection can significantly impact experimental outcomes, with recombinant secondary antibodies offering advantages in terms of reduced batch-to-batch variation and higher specificity .

What are common problems encountered with RINO1 antibodies and their solutions?

Researchers frequently encounter specific challenges when working with plant protein antibodies like those targeting RINO1:

Common Issues and Solutions:

ProblemPossible CausesRecommended Solutions
No signal in Western blotProtein denaturation affecting epitope recognitionTry native conditions or different extraction buffers
Low RINO1 expressionEnrich samples through subcellular fractionation or concentrate proteins
Inefficient transferOptimize transfer conditions for high molecular weight proteins
High background in IHCNon-specific bindingIncrease blocking time/concentration; try different blocking agents (milk, BSA, normal serum)
Autofluorescence from plant tissuesUse Sudan Black B treatment; employ spectral unmixing
Insufficient washingIncrease wash duration and volume; add mild detergent to wash buffer
Multiple bands in Western blotProtein degradationAdd fresh protease inhibitors; maintain cold chain during extraction
Post-translational modificationsUse phosphatase inhibitors; perform enzymatic treatments to confirm
Splice variantsCompare with transcript data; use domain-specific antibodies

For RINO1 specifically, including phosphatase inhibitors is crucial as the inositol phosphate pathway involves numerous phosphorylated intermediates .

How can RINO1 antibodies be used to study the relationship between inositol metabolism and auxin signaling?

RINO1 antibodies enable sophisticated studies of the inositol-auxin signaling axis:

Integrated Research Approaches:

  • Co-localization Studies:

    • Double immunolabeling of RINO1 with auxin transporters (PIN proteins)

    • Correlative microscopy combining RINO1 immunolocalization with auxin reporters (DR5)

    • Subcellular co-localization with phosphoinositide markers

  • Functional Perturbation Analysis:

    • Track RINO1 protein levels and localization following auxin treatment

    • Compare RINO1 distribution in wild-type vs. auxin signaling mutants

    • Monitor effects of RINO1 manipulation on auxin-responsive gene expression

  • Molecular Interaction Studies:

    • Investigate RINO1 associations with vesicle trafficking components

    • Analyze changes in protein complexes following auxin treatment

    • Study phosphorylation status of RINO1 in response to auxin signaling

Research has established that abnormal embryo phenotypes in RINO1 knockouts can be partially rescued by exogenous application of both inositol and IAA, suggesting intimate connections between these pathways that can be further elucidated using antibody-based approaches .

How can synthetic biology approaches be used to generate improved RINO1 antibodies?

Modern synthetic biology offers promising avenues for developing superior RINO1 antibodies:

Innovative Antibody Engineering Approaches:

  • AI-Driven Antibody Design:

    • Utilize deep learning models like RFdiffusion to design antibody binding regions targeting RINO1-specific epitopes

    • Apply computational approaches to optimize antibody stability and specificity

    • Use in silico epitope prediction to target highly specific regions of RINO1

  • Recombinant Antibody Technologies:

    • Generate single-chain variable fragments (scFvs) with enhanced tissue penetration

    • Develop bispecific antibodies that simultaneously target RINO1 and associated proteins

    • Create synthetic Notch receptor-based systems for context-dependent RINO1 detection

  • Logic-Gated Recognition Systems:

    • Design antibody-based sensors that respond only when multiple RINO1-associated epitopes are present

    • Develop conditional detection systems activated only in specific cellular contexts

    • Create synNotch receptor systems that induce expression of secondary detection mechanisms

Recent advances in AI-driven antibody design, as demonstrated by RFdiffusion technology, allow for generation of human-like antibodies with customized binding properties, which could significantly improve RINO1 detection systems .

What approaches can be used to study the dynamics of RINO1 protein in living plant cells?

To investigate RINO1 dynamics in living systems:

Live Cell Analysis Methods:

  • Fluorescent Protein Fusion Approaches:

    • Generate RINO1-FP fusion constructs under native promoters using CRISPR/Cas9

    • Validate functionality of fusion proteins through complementation assays

    • Use photoactivatable or photoconvertible fluorescent proteins to track protein movement

  • Antibody Fragment-Based Live Imaging:

    • Develop cell-penetrating antibody fragments (nanobodies) against RINO1

    • Conjugate fluorescent dyes to Fab fragments for live cell immunolabeling

    • Create genetically encoded intrabodies expressed within plant cells

  • Advanced Microscopy Techniques:

    • Implement FRAP (Fluorescence Recovery After Photobleaching) to study RINO1 mobility

    • Apply FRET-based approaches to monitor RINO1 interactions with binding partners

    • Use light-sheet microscopy for long-term 4D imaging of RINO1 dynamics during development

While traditional antibodies are primarily used in fixed samples, these advanced approaches enable the study of dynamic processes involving RINO1 in living plant tissues.

How can RINO1 antibodies contribute to understanding evolutionary conservation of inositol signaling across plant species?

RINO1 antibodies can provide valuable insights into evolutionary aspects of inositol signaling:

Comparative Evolutionary Approaches:

  • Cross-Species Reactivity Analysis:

    • Test RINO1 antibody recognition across diverse plant species

    • Map epitope conservation through sequence alignment and structural modeling

    • Correlate antibody reactivity patterns with phylogenetic relationships

  • Comparative Expression Studies:

    • Analyze RINO1 protein localization patterns across evolutionarily diverse plant species

    • Compare subcellular distribution in monocots vs. dicots

    • Document developmental expression differences between species with varying seed structures

  • Structure-Function Conservation Analysis:

    • Combine antibody-based detection with functional assays across species

    • Correlate protein abundance with enzymatic activity in different plant lineages

    • Map conserved and divergent protein interaction networks across evolutionary distance

This comparative approach can reveal fundamental aspects of inositol metabolism that have been conserved throughout plant evolution, as well as lineage-specific adaptations that may relate to specialized developmental strategies.

How might next-generation antibody technologies enhance RINO1 research in the coming years?

Emerging technologies promise to revolutionize RINO1 antibody applications:

Future Technological Innovations:

  • Single-Cell Analysis Technologies:

    • Single-cell Western blot systems for cell-specific RINO1 quantification

    • Mass cytometry (CyTOF) adapted for plant cells to simultaneously detect multiple proteins

    • Spatial proteomics approaches to map RINO1 distribution at subcellular resolution

  • Advanced Multiplexing Capabilities:

    • Cyclic immunofluorescence to detect 20+ proteins in the same tissue section

    • Oligonucleotide-conjugated antibodies for highly multiplexed detection

    • Combinatorial antibody coding for simultaneous tracking of multiple protein variants

  • Integrative Multi-Omics Approaches:

    • Combined antibody-based proteomics with metabolomics of inositol pathway intermediates

    • Integration of RINO1 protein data with transcriptomics and epigenomics

    • Correlation of RINO1 dynamics with real-time metabolite imaging

Recent research has demonstrated the value of recombinant antibodies, which on average outperform both monoclonal and polyclonal antibodies across multiple applications, suggesting increased adoption of recombinant technologies for RINO1 studies .

What are the current limitations in RINO1 antibody research that require methodological innovations?

Current limitations and potential solutions in RINO1 antibody research:

Research Gaps and Innovative Solutions:

  • Tissue Penetration Challenges:

    • Current limitation: Poor penetration into dense seed tissues

    • Innovation needed: Development of smaller antibody formats (nanobodies, affimers)

    • Potential solution: Optimization of clearing techniques compatible with immunolabeling

  • Temporal Resolution Limitations:

    • Current limitation: Static snapshots of RINO1 distribution

    • Innovation needed: Real-time sensors for RINO1 activity or concentration

    • Potential solution: Development of RINO1-specific biosensors based on binding domains

  • Quantification Accuracy Issues:

    • Current limitation: Semi-quantitative nature of many antibody-based assays

    • Innovation needed: Standardized absolute quantification methods

    • Potential solution: Implementation of digital PCR-like approaches for protein quantification

  • Cross-Reactivity Concerns:

    • Current limitation: Potential recognition of related inositol synthases

    • Innovation needed: Enhanced epitope mapping and antibody engineering

    • Potential solution: Application of AI-driven antibody design to target unique epitopes

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.